-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

ASH Clinicians in Practice (ACIP) Lunch - The Role of Artificial Intelligence in Hematology Practice: The Good, the Bad, and the Ugly

Program: Special-Interest Sessions
Sunday, December 8, 2024: 11:15 AM-12:30 PM
Marina Ballroom DE (Marriott Marquis San Diego Marina)
Chair:
Mary-Elizabeth M. Percival, MD, Seattle Cancer Care Alliance
Disclosures:
No relevant conflicts of interest to declare.

Artificial Intelligence (AI) has the potential to transform health care by enhancing diagnostic accuracy, predicting patient outcomes, and developing personalized treatment plans. Machine learning algorithms can analyze vast amounts of medical data, leading to more efficient and precise health care interventions, which could improve patient care and reduce costs. However, implementation of AI in health care also poses challenges related to data privacy concerns, ethical considerations, and the need for robust regulatory frameworks to ensure the responsible and secure use of sensitive medical information. In this session, panelists will speak on the recent advances and use of AI in health care, how it’s integrated into hematology practice by providers, and the use of AI by patients.

Jim Whitfill, MD MBA FACP FSIIM

HonorHealth, Phoenix, AZ; University of Arizona College of Medicine Phoenix, Phoenix, AZ

Christopher Manz, MD, MSHP

Dana-Farber Cancer Institute, Boston, MA

Gwen L Nichols, MD

The Leukemia & Lymphoma Society, Rye Brook, NY